In summary, these data show that biological functions of CUGBP1 are altered in DM1 patients not only by the elevation of the protein, but also by phosphorylation-specific changes in RNA-binding activity of CUGBP1. The gene discussed is CELF1; the disease is myotonic dystrophy type 1.